CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Teneobio, Inc.

For profitWebsite ↗

Also known as: Teneobio, Inc. | TeneoOne Inc. | TeneoTwo Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 1

First clinical trial

Last known activity

Apr 1, 2023

Acquired by Amgen on Jul 28, 2021

Timeline

2000s

Jun 1, 2009
Teneobio, Inc.— Founded

2020s

Jul 28, 2021
Amgen— Acquired By

Drugs by trial phase (9 distinct, 6 trials)

Phase 1 (9 own, 0 via acquisition)

Indications

Studied for

Recent trials (12)

NCT04453397Lead sponsorN/A—
NCT04453397Study chairN/A—
NCT05650632Lead sponsorPhase 1Apr 1, 2023
NCT05650632Study directorPhase 1Apr 1, 2023
NCT05259839Lead sponsorPhase 1Oct 20, 2022
NCT05259839Study directorPhase 1Oct 20, 2022
NCT04740034Study chairPhase 1Apr 29, 2021
NCT04740034Lead sponsorPhase 1Apr 29, 2021
NCT04594642Study chairPhase 1Mar 2, 2021
NCT04594642Lead sponsorPhase 1Mar 2, 2021
NCT03933735Lead sponsorPhase 1Jun 30, 2019
NCT03933735Study chairPhase 1Jun 30, 2019

Details

Founded: Newark, CA, US Jun 1, 2009
Last known activity: Apr 1, 2023